Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Sequentia Biotech Sl |
| Country | Spain |
| Start Date | Sep 01, 2022 |
| End Date | Feb 28, 2025 |
| Duration | 911 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190195702 |
Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess and monitor it.
Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming.We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice.
MICK automated platform analyses microbiome raw data in real-time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations.MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining up to 75% cost reduction and faster TAT compared to existing solutions.
Sequentia Biotech Sl
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant